The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glofitamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and ≥ 2 prior therapies: Pivotal phase II expansion results.
 
Michael Dickinson
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche (I)
Research Funding - Celgene (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche
 
Carmelo Carlo-Stella
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene/Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Incyte; Janssen Oncology; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Karyopharm Therapeutics; Novartis; Roche; Sanofi
Research Funding - ADC Therapeutics (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics; Janssen; Roche; Takeda
 
Franck Morschhauser
Honoraria - Chugai/Roche; Eisai; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; epizyme; Genmab; Gilead Sciences; Novartis; Roche/Genentech; SERVIER
Expert Testimony - Roche/Genentech
 
Emmanuel Bachy
Honoraria - Amgen; Gilead Sciences; Janssen-Cilag; Novartis; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Incyte; Roche; Takeda
Research Funding - Amgen Foundation (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Incyte; Janssen-Cilag; Roche
 
Paolo Corradini
Honoraria - Abbvie; Amgen; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; KiowaKirin; Kite, a Gilead company; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Daiichi Sankyo; Gilead Sciences; Incyte; Janssen; Jazz Pharmaceuticals; KiowaKirin; Kite/Gilead; Nerviano Medical Sciences; Novartis; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Abbvie; Celgene; Gilead Sciences; Janssen; Kite, a Gilead company; Novartis; Takeda
 
Gloria Iacoboni
Honoraria - AstraZeneca Spain; Celgene/Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Novartis; Roche/Genentech
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Celgene/Bristol-Myers Squibb; Gilead Sciences; Novartis
 
Cyrus Khan
Consulting or Advisory Role - AstraZeneca; Roche
Speakers' Bureau - Abbvie; Acrotech Biopharma; ADC Therapeutics; AstraZeneca; BeiGene; GlaxoSmithKline; Incyte; Janssen; Karyopharm Therapeutics; MorphoSys; Roche; Seagan
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Roche (Inst)
 
Tomasz Wrobel
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen-Cilag; Roche
Consulting or Advisory Role - Abbvie; Amgen; Janssen-Cilag; Novartis; Roche/Genentech; Takeda
Research Funding - Roche
 
Fritz Offner
No Relationships to Disclose
 
Marek Trneny
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Gilead Sciences; janssen; Roche; Takeda
 
Shang-Ju Wu
Honoraria - Johnson & Johnson/Janssen; Ono Pharmaceutical; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - AstraZeneca/MedImmune
 
Guillaume Cartron
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Celgene; Mabqi; MedxCell; Roche
Travel, Accommodations, Expenses - Roche
 
Mark Hertzberg
Honoraria - Janssen; Roche/Genentech
Consulting or Advisory Role - BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Anna Sureda Balari
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Kite/Gilead
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
David Perez-Callejo
Employment - Bristol-Myers Squibb/Celgene; Roche
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene; Roche
 
Linda Lundberg
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
James Relf
Employment - Roche
Stock and Other Ownership Interests - F-Star Biotechnology; Harpoon therapeutics; Roche
 
Emma Clark
Employment - Roche
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Issued patent: Uses for and article of manufacture including HER2 dimerization inhibitor pertuzumab, 13/649591
 
Kathryn Humphrey
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Martin Hutchings
Consulting or Advisory Role - Genmab; Janssen; Roche; Takeda
Research Funding - Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)